DeBio Network Strategic Round Closes as Number of Investors Hits Record Highs

DeBio Network successfully went through the strategic round receiving overwhelming interest from investors

DeBio Network
DeBio Network

--

Image retrieved from the DeBio Deck

DeBio Network has closed the strategic investment round for the platform, totaling $500,000. DeBio Network succeeded in raising the capital for the strategic round and was 5x oversubscribed.

The strategic round opened in July and was initially planned to end in August, but because of the overwhelming interest from investors, we decided to prolong the strategic round until the 5th of October.

We are delighted that so many people are interested in our project and would like to see it succeed. Currently, we are preparing for our initial dex offering (IDO) on Skyward.finance later next month and we are working extra hard with the team on Octopus Network to make this possible.

Since the closing of the strategic round, the fully diluted valuation of the DeBio Network has reached USD 10 million (10 cents for every 100 million $DBIO).

About DeBio Network

DeBio Network is a decentralized anonymous-first platform for medical and bioinformatics data specializing in genetics testing. We take your privacy concerns seriously and we are making the anonymous-first genetic testing application that would not only guarantee your data sovereignty but would also be easy-to-use and would be accessible.

Our partners include the Octopus Network a multi-chain network that is designed to bootstrap application-specific blockchains, KILT a protocol for verifying identities anonymously on Web3, Ref.finance the first major DeFi platform running on NEAR Protocol, and Skyward.finance a fully permissionless open-source launchpad.

Preparing the “World DeBio Day”

The DeBio Network is the first Appchain to register on the Octopus Network and is aiming to be the first live Appchain in the Octopus Network. Essentially our Appchain has the opportunity to be the first among many blockchains and can potentially spearhead the development of this platform.

The future is here, DeBio is creating solutions to revolutionize the healthcare and genetic testing industry. Are you ready to change the world with us?

--

--